Antioxidant supplementation and cancer prevention

JAMA

Volumn 301, Issue 18, 2009, Pages 1878-

  Pinsky, Paul F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PROSTATE SPECIFIC ANTIGEN; ALPHA TOCOPHEROL; SELENIUM;

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE INTERVAL; HUMAN; LETTER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; DIET SUPPLEMENTATION; MALE; NOTE; PROSTATE TUMOR; SURVIVAL;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; MALE; PROSTATIC NEOPLASMS; SELENIUM; SURVIVAL ANALYSIS; VITAMIN E;

EID: 65549127582     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.629     Document Type: Letter

References (4)

1. Gann PH. Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance - next, cause. JAMA. 2009;301(1):102-103.
2. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51.
3. Surveillance, Epidemiology and End Results (SEER) Program statistics database. http://www.seer.cancer.gov. Accessed March 3, 2009.
4. Grubb RL III, Pinsky P, Greenlee R, et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int. 2008;102(11):1524-1530.